Ann: RESUBMISSION - Quarterly Update and Appendix 4C, page-44

Perhaps. We'll see. Either way its good Risk/Reward and I am still perplexed as to why IHL isnt getting the interest it deserves.

But of course, we'll get the FOMO pile in when the OSA trial shows results...

A bit of research reveals dronabinol already works for sleep apnea.... (RespireRX Phase 2 Trial)
But they have no patent in Aus and our IHL-42X based off dronabinol is a novel formulation..

Hehe. Repeat of 2019 anyone?